GlassScriptPhysician profile
Bradley D Bilton
NPI 1639179740
$2,386.80
in general payments reported to CMS, 2019-2025
32 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,526 · 2020: $127 · 2021: $139 · 2022: $147 · 2023: $185 · 2024: $154 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,506.73 | 2019-2021 | |
| Ethicon US, LLC | $124.53 | 2019-2024 | Echelon Flex |
| Smith+Nephew, INC. | $76.37 | 2022-2023 | Renasys Go V2 Home, N/A |
| Portola Pharmaceuticals, LLC | $55.81 | 2019-2020 | |
| Kerecis Limited | $49.98 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $49.88 | 2021-2023 | Signia |
| Intra-Sana Laboratories | $45.00 | 2021-2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Conmed Corporation | $33.38 | 2025 | Airseal, Conmed Specimen Retrieval |
| Octapharma USA, INC. | $32.97 | 2025 | Fibryga |
| Lemaitre Vascular, INC. | $30.89 | 2023 | Artegraft Vascular Graft |
| Integra Lifesciences Corporation | $28.92 | 2022 | |
| Covidien LP | $27.68 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $24.18 | 2019-2020 | |
| Allergan, INC. | $22.21 | 2019 | |
| W. L. Gore & Associates, INC. | $22.01 | 2024 | Gore Synecor Biomaterial |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $20.62 | 2019 | |
| Becton, Dickinson and Company | $20.20 | 2022 | |
| Stryker Corporation | $18.80 | 2023 | 1788 |
| Coopersurgical, INC. | $17.62 | 2021 | |
| Kci USA, INC. | $16.79 | 2020 | |
| Tela Bio, INC. | $16.03 | 2022 | |
| Hologic Sales and Service, LLC | $15.46 | 2024 | Trunode |
| Polynovo North America LLC | $15.42 | 2022 | |
| Innovation Technologies INC | $15.10 | 2023 | Irrisept |
| Tei Biosciences INC | $15.03 | 2019 | |
| Sanara Medtech INC. | $14.38 | 2023 | Celleraterx |
| Teleflex LLC | $14.14 | 2025 | Titan Sgs Bailout Chuck |
| Baxter Healthcare | $12.81 | 2022 | |
| Misonix INC | $12.10 | 2019 | |
| Eisai INC. | $11.74 | 2019 | |
| Apollo Endosurgery US INC | $10.22 | 2019 | |
| Medela LLC | $9.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Bilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.